rad35
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00801697)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rad35
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01095224 | Phase 1 | Sep 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00801697 | Phase 1 | Feb 1, 2009 | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, University of Lausanne |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2009 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Lausanne | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2010 |
5 organizations
Page 1 / 1